Amicoat

Description

Amicoat provides antimicrobial coating technology for medical devices using voxvoganan, an antimicrobial peptide, and supports partners testing its incorporation into relevant device materials with regulatory documentation for development processes.

Amicoat is located in the Oslo ecosystem.

Related

• GradientechGradientech develops the QuickMIC system for ultra-rapid phenotypic antibiotic susceptibility testing, producing precise MIC values for…
• VirtonomyVirtonomy develops digital patient twins and medical simulation platforms that let device developers run data-driven virtual patient…
• BachemBachem provides peptide and oligonucleotide development and GMP manufacturing services (CDMO) for pharmaceutical and biotechnology…
• NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
• ActiTrexxActiTrexx develops therapies based on activated regulatory T cells for autoimmune and autoinflammatory diseases, including ATreg/Actileucel…
• EnzyTagEnzyTag develops peptiligase-based synthetic routes for manufacturing peptide new chemical entities, small proteins, and peptide…
• ParolParol is an ambient AI assistant that transcribes doctor–patient conversations and converts them into HIPAA‑compliant medical notes,…
• 21st.BIO21st.BIO A/S provides precision fermentation technology for proteins and peptides, using microbial strains, fermentation processes, and…
• OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…